Effects of dopamine on prolactin secretion and cyclic AMP accumulation in the rat anterior pituitary gland
- 15 January 1981
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 194 (1) , 119-128
- https://doi.org/10.1042/bj1940119
Abstract
The effects of dopamine on pituitary prolactin secretion and pituitary cyclic AMP accumulation were studied by using anterior pituitary glands from adult female rats, incubated in vitro. During 2h incubations, significant inhibition of prolactin secretion was achieved at concentrations between 1 and 10nm-dopamine. However, 0.1–1μm-dopamine was required before a significant decrease in pituitary cyclic AMP content was observed. In the presence of 1μm-dopamine, pituitary cyclic AMP content decreased rapidly to reach about 75% of the control value within 20min and there was no further decrease for at least 2h. Incubation with the phosphodiesterase inhibitors theophylline (8mm) or isobutylmethylxanthine (2mm) increased pituitary cyclic AMP concentrations 3- and 6-fold respectively. Dopamine (1μm) had no effect on the cyclic AMP accumulation measured in the presence of theophylline, but inhibited the isobutylmethylxanthine-induced increase by 50%. The dopamine inhibition of prolactin secretion was not affected by either inhibitor. Two derivatives of cyclic AMP (dibutyryl cyclic AMP and 8-bromo cyclic AMP) were unable to block the dopamine (1μm) inhibition of prolactin secretion, although 8-bromo cyclic AMP (2mm) significantly stimulated prolactin secretion and both compounds increased somatotropin (growth hormone) release. Cholera toxin (3μg/ml for 4h) increased pituitary cyclic AMP concentrations 4–5-fold, but had no effect on prolactin secretion. The inhibition of prolactin secretion by dopamine was unaffected by cholera toxin, despite the fact that dopamine had no effect on the raised pituitary cyclic AMP concentration caused by this factor. Dopamine had no significant effect on either basal or stimulated somatotropin secretion under any of the conditions tested. We conclude that the inhibitory effects of dopamine on prolactin secretion are probably not mediated by lowering of cyclic AMP concentration, although modulation of the concentration of this nucleotide in some other circumstances may alter the secretion of the hormone.This publication has 26 references indexed in Scilit:
- β-Endorphin-Induced Decrease in Hypothalamic Dopamine Turnover*Endocrinology, 1980
- Endogenous opiates block dopamine inhibition of prolactin secretion in vitroNature, 1979
- The Effects of Opiate Agonist and Antagonist on Serum Prolactin in Primates: Possible Role for Endorphins in Prolactin Regulation*Endocrinology, 1979
- Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomasNature, 1979
- Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cellsMolecular and Cellular Endocrinology, 1978
- Hypothalamic Regulatory HormonesAnnual Review of Biochemistry, 1978
- Dibutyryl Cyclic AMP, Adenosine and Guanosine Blockade of the Dopamine, Ergocryptine and Apomorphine Inhibition of Prolactin Releasein Vitro1Endocrinology, 1976
- Growth Hormone Releasing Factor of Microbial OriginNature, 1974
- Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†Journal of Clinical Endocrinology & Metabolism, 1971
- Prostaglandin E1 and the Release of Growth Hormone in VitroNature, 1970